Kynam Capital Management »

Morphosys shares owned by Kynam Capital Management

Quarter-by-quarter ownership of Morphosys (MOR) shares owned by Kynam Capital Management from 13F filings

Historical chart of Kynam Capital Management investment in Morphosys

Tip: Access up to 7 years of quarterly data

All positions including Morphosys held by Kynam Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Morphosys by Kynam Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $42M 4.2M 9.90

More positions owned by Kynam Capital Management

Natera (NTRA)
Syndax Pharmaceuticals (SNDX)
Celldex Therapeutics Com New (CLDX)
Vaxcyte (PCVX)
Vera Therapeutics Cl A (VERA)
Protagonist Therapeutics (PTGX)
ImmunoGen
Morphosys Sponsored Ads (MOR)
Cogent Biosciences (COGT)
Liquidia Corporation Com New (LQDA)
BioCryst Pharmaceuticals (BCRX)
2seventy Bio Common Stock (TSVT)
Dynavax Technologies Corp Com New (DVAX)
Wave Life Sciences SHS (WVE)
Corcept Therapeutics Incorporated Put Option (CORT)

View all positions for Kynam Capital Management

Top funds holding Morphosys

Kynam Capital Management
Point72 Asset Management
T. Rowe Price Associates
Logos Global Management
Caption Management
Ikarian Capital
TD Asset Management
Citadel Advisors
Millennium Management
Marshall Wace
Goldman Sachs Group
TIG Advisors
Cubist Systematic Strategies
Two Sigma Investments
Opaleye Management

View all funds holding Morphosys